These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8241956)

  • 1. The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors.
    Grillon C; Bonnet D; Mary JY; Lenfant M; Najman A; Guigon M
    Stem Cells; 1993 Sep; 11(5):455-64. PubMed ID: 8241956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP.
    Guigon M; Bonnet D; Lemoine F; Kobari L; Parmentier C; Mary JY; Najman A
    Exp Hematol; 1990 Nov; 18(10):1112-5. PubMed ID: 2209766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
    J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of interleukin-3 on zidovudine (AZT)-induced in vitro toxicity to human hematopoietic progenitors.
    Gallicchio VS; Hughes NK
    Int J Cell Cloning; 1992 Mar; 10(2):99-104. PubMed ID: 1545155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S; Media JE; Nakeff A
    Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS; Hughes NK; Tse KF
    Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells.
    Bonnet D; Césaire R; Lemoine F; Aoudjhane M; Najman A; Guigon M
    Exp Hematol; 1992 Feb; 20(2):251-5. PubMed ID: 1544396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
    Bhalla K; Birkhofer M; Grant S; Graham G
    Exp Hematol; 1989 Jan; 17(1):17-20. PubMed ID: 2783247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoprotection of normal human hematopoietic progenitors by the tetrapeptide N-AcSDKP.
    Coutton C; Guigon M; Bohbot A; Ferrani K; Oberling F
    Exp Hematol; 1994 Oct; 22(11):1076-80. PubMed ID: 7925774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demonstration of a protector effect of interleukin-1 against hematologic toxicity of azidothymidine (AZT)].
    Arock M; Dedenon A; Damais C; Averlant G; Guillosson JJ
    C R Seances Soc Biol Fil; 1992; 186(3):206-14. PubMed ID: 1493577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
    Jackson JD; Yan Y; Ewel C; Talmadge JE
    Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of the hematopoietic toxicity associated with zidovudine in vivo with IL-1 alone or in combination with GM-CSF administered to normal mice.
    Gallicchio VS; Hughes NK; Tse KF; Gaines H
    Growth Factors; 1993; 9(3):177-83. PubMed ID: 8274295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
    Ganser A; Greher J; Völkers B; Staszewski S; Hoelzer D
    Exp Hematol; 1989 May; 17(4):321-5. PubMed ID: 2540017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible inhibitory effects and absence of toxicity of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture.
    Bonnet D; Lemoine FM; Khoury E; Pradelles P; Najman A; Guigon M
    Exp Hematol; 1992 Nov; 20(10):1165-9. PubMed ID: 1385195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK; Konings AW
    Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice.
    Prakash O; Rodriguez VE; Tang ZY; Zhou P; Coleman R; Dhillon G; Shellito JE; Nelson S
    Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro toxicity of A 3'-azido-3'-deoxythymidine and hydroxyurea combination on normal myeloid progenitors.
    Lerza R; Castello G; Ballarino P; Mela GS; Tredici S; Arboscello E; Mencoboni M; Pannacciulli I
    Anticancer Res; 1998; 18(4A):2755-8. PubMed ID: 9703941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.